BUNKA CHRISTOPHER
SEC insider (Form 3/4/5 filer). CIK 0001103780. Director at Lexaria Bioscience Corp. (LEXX). 5 reported Form 4/5 transactions since Sep 2024; latest on Mar 17, 2026. Located in KELOWNA.
Companies BUNKA CHRISTOPHER has filed insider reports for
- Lexaria Bioscience Corp. (LEXX): Director
BUNKA CHRISTOPHER
CIK: 0001103780
Transaction Breakdown
Open Market Buys (P)2 (40.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXX
Lexaria Bioscience Corp.
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Mar 17, 2026LEXX
Lexaria Bioscience Corp.
GiftDirect100K shares- - Jul 30, 2025LEXX
Lexaria Bioscience Corp.
PurchaseIndirect11.9K shares at avg. $0.91$11K - Jul 29, 2025LEXX
Lexaria Bioscience Corp.
PurchaseIndirect15.6K shares at avg. $0.92$14K - May 15, 2025LEXX
Lexaria Bioscience Corp.
AwardDirectStock Options
11K shares- - Jan 7, 2025LEXX
Lexaria Bioscience Corp.
AwardDirect100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 17, 2026 | LEXX Lexaria Bioscience Corp. | Gift | 100,000 | - | $0 | Direct |
| Jul 30, 2025 | LEXX Lexaria Bioscience Corp. | Purchase | 11,900 | $0.91 | $10,866 | Indirect |
| Jul 29, 2025 | LEXX Lexaria Bioscience Corp. | Purchase | 15,600 | $0.92 | $14,375 | Indirect |
| May 15, 2025 | LEXX Lexaria Bioscience Corp. | Award Stock Options | 11,000 | - | - | Direct |
| Jan 7, 2025 | LEXX Lexaria Bioscience Corp. | Award | 100,000 | - | $0 | Direct |
1-5 of 5 transactions